Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

By Peter M. Rothwell, Michelle Wilson, J. Price, J. Belch, T. Meade, Z. Mehta. The Lancet, 2012

942 citations recorded by the source corpus.

Subfields: Biotechnology, Cancer Research, Pharmacology

View Paper: https://www.semanticscholar.org/paper/4ae26bd07a7b0c17943bee221558e3b0d97fd55b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. S. Grivennikov
2. F. Greten
3. M. Karin

Citations in the corpus

• Inflammation and Cancer: Triggers, Mechanisms and Consequences (2019, background): “These evidences include large clinical studies on “non-specific” inhibition of inflammation with non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, reducing incidence and mortality in many cancers (Rothwell et al., 2011; Rothwell et al., 2012); or specific inhibition of cytokines such a”
• Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival (2012, neutral): “Poorly differentiated 78/958 (8) 39/461 (8) 26/337 (8) 9/94 (10) 4/66 (6)”